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SUMMARY
Aortic stenosis (AS) is common in the elderly and is associated with an increased risk of death from cardiovas-
cular events. Nevertheless, acute myocardial infarction (AMI) in patients with severe AS and “normal” coronary
arteries is very rare. We present an elderly male with severe AS and angiographically normal coronary arteries
who experienced AMI. Platelet hyperaggregability, activation of blood coagulation, coronary microcirculatory
dysfunction, imbalance of supply and demand in the hypertrophied myocardium, and subendocardial ischemia
predisposed by AS are possible mechanisms. The relevant literature is reviewed and discussed in the report.
[International Journal of Gerontology 2010; 4(3): 157–160]
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Introduction
Previous studies demonstrated that older persons with
aortic stenosis (AS) have a higher prevalence of coronary
risk factors, a higher prevalence of coronary artery dis-
ease, and a higher incidence of new coronary events1–3.
Nevertheless, acute myocardial infarction (AMI) in
patients with severe AS and “normal” coronary arteries
is very rare. We present a 79-year-old male with severe
AS and left ventricular hypertrophy who suffered an AMI.
Coronary angiography excluded coronary obstruction
as the cause of the AMI in this patient. Platelet hyper-
aggregability, activation of blood coagulation, coronary
microcirculatory dysfunction, imbalance of oxygen sup-
ply and demand in the hypertrophied myocardium,
and subendocardial ischemia predisposed by AS are
possible mechanisms to explain this serious event.
Case Report
A 79-year-old male with a medical history of hyperten-
sion and chronic renal insufficiency presented to our
emergency department with complaints of chest dis-
comfort and heaviness for 3 hours. Two months prior
to visiting our emergency department, he had been
admitted to our ward of cardiology for 1 week because
of angina pectoris and heart failure. Echocardiography
showed severe AS with estimated valve area 0.8 cm2
and low left ventricular ejection fraction. Aortic valve
replacement with preoperative coronary angiography
was suggested but the patient refused. He was then
discharged and received regular outpatient follow-up.
Antihypertensive medications and aspirin were pre-
scribed. On arrival at our emergency department, his
electrocardiogram revealed regular sinus rhythm with
ST-segment depression in lead II, III, aVF and V4-6,
which was the same as that from his previous visit.
Initial biochemical data of cardiac enzymes were crea-
tine kinase (CK), 224 U/L; CK-MB, 13.6 U/L; troponin-I,
4.96 ng/mL. He was admitted to our intensive care unit
under the impression of non-ST segment elevation
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myocardial infarction. Intravenous infusion of nitro-
glycerin and subcutaneous injection of low molecular
weight heparin were prescribed in the intensive care
unit. Aspirin and clopidogrel were also prescribed.
Coronary angiography was performed by an interven-
tional cardiologist 18 hours after onset of the symptoms
and revealed normal coronary arteries with nonsigni-
ficant obstructive lesions (Figure 1). The peak cardiac
enzymes recorded at 20 hours after appearance of the
symptoms were CK, 516U/L; CK-MB, 30.8U/L; troponin-I,
7.80 ng/mL. After medical treatment, he was discharged
6 days later with no further event.
Discussion
In developed countries, AS is the most prevalent of all
valvular heart diseases. A clear increase in the pre-
valence of AS is seen with age: 1.3% in patients aged
65–75 years, 2.4% in those aged 75–85 years, and 4%
in those older than 85 years4. Previous studies indi-
cated that AS, even in its early phases, may be associated
with the pathogenesis of acute coronary syndromes1–3.
About 20–50% of subjects with AS and angina pectoris
have significantly obstructive coronary artery disease
(CAD)3,5. Although most patients with AS are of an age
at which CAD is prevalent, AMI with severe AS and
“normal” coronary arteries is rarely reported6. On the
other hand, the overall rate of AMI in patients with
normal coronary angiography ranges from 1% to 12%7.
Disparate etiologic factors have been implicated, includ-
ing transient occlusion of the infarct-related artery
owing to platelet hyperactivity and thrombosis, coronary
artery spasm, cocaine abuse, acute alcohol intoxica-
tion, ingestion of ephedrine-containing drugs, with-
drawal from calcium channel blockers, and coronary
embolization7. Patients in this group appear to be
younger and less likely to have traditional risk factors
for atherosclerosis than those with documented coro-
nary disease8. It is of interest that, in this report, the
79-year-old male with severe AS and common CAD
risks suffered from an AMI despite angiographically
normal coronary arteries. Mechanisms other than
obstructive CAD predisposed by severe AS perhaps play
an important role in such events.
Chirkov et al.9 reported that AS was associated with
platelet hyperaggregability, irrespective of the presence
and/or absence of CAD. Thrombin generation and plate-
let activation were enhanced in patients with AS10,11,
and a maximal transvalvular pressure gradient was
the only independent predictor of these hemostatic
processes11. All three platelet activation markers, i.e.,
soluble CD40 ligand, P-selectin, and beta-thromboglob-
ulin were higher in AS patients than in healthy individ-
uals (more than 2-fold increase in solubleCD40 ligand
and P-selectin)11. Also, levels of all the hemostatic vari-
ables were higher in AS patients than in patients with
hypertrophic obstructive cardiomyopathy and sinus
rhythm10, indicating that higher transvalvular pressure
gradient is a much more potent trigger for blood clot-
ting11. The mechanism underlying thrombin generation
and platelet activation in the AS patients appeared to
be closely linked to altered hemodynamic properties
of blood flow in the presence of severe aortic valve
stenosis. However, it is still uncertain that antiplatelet
or anticoagulant therapy are effective in preventing
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Figure 1. Selective coronary angiography showing (A) nonsignificant obstructive lesions of left anterior descending and 
circumflex artery (RAO, cranial view), and (B) patent right coronary artery (LAO view).
thrombin generation and platelet activation predis-
posed by AS.
In addition to thrombin generation and platelet
activation, left ventricular hypertrophy predisposed by
AS can lead to microcirculatory dysfunction, even when
the coronary arteries are normal12. In a recent study
reported by Miyagawa et al.12, who used myocardial
contrast echocardiography to evaluate the deteriora-
tion of blood flow in the hypertrophied myocardium
of AS patients, the myocardial blood flow in the suben-
docardium was significantly lower than that in normal
individuals, whereas there was no significant difference
in the subepicardial blood flow. Decreased subendo-
cardial blood flow implies myocardial microcirculatory
dysfunction and reduced coronary vasodilator reserve13.
This impairment could be secondary to perimyocytic
fibrosis12 and reduced capillary ingrowth into the hyper-
trophied myocardium4. Additionally, the increased filling
pressure needed to distend the thickened ventricular
wall compresses the endocardium, further impairing
blood flow to that layer of the myocardium. These ab-
normalities may contribute to the induction of suben-
docardial ischemia in AS patients who have normal
epicardial coronary arteries4. According to the report
by Miyagawa et al.12, the reduced subendocardial blood
flow and microcirculatory dysfunction recovered signi-
ficantly at 2 weeks after aortic valve replacement and
this improvement was still present at a 1-year follow-
up. Although aortic valve replacement is indicated 
in symptomatically severe AS14, it remains unclear
whether it can reduce the rate of AMI in patients with
severe AS.
In our report, a 79-year-old male with a history of
symptomatically severe AS and hypertension suffered
from AMI with typical ischemic angina and elevation of
cardiac enzymes. Coronary angiography was performed
and unexpectedly revealed normal coronary arteries.
It reminded us that AMI can occur in AS patients by
means of altered hemostatic and hemodynamic prop-
erties even without obstructive CAD. To our knowledge,
this is the first case report in Taiwan of AMI occurring
in a patient with severe AS and angiographically normal
coronary arteries.
In conclusion, thrombin generation and platelet
activation can be enhanced by AS despite antiplatelet
or anticoagulant therapy. Left ventricular hypertrophy
predisposed by AS can lead to decreased blood flow in
the subendocardium and impaired coronary vasodila-
tory reserve. A high filling pressure produced by the
hypertrophied myocardium compresses the endocar-
dium and contributes to subendocardial ischemia. These
abnormalities are possible mechanisms to explain AMI
occurring in elderly patients who have severe AS and
common CAD risks but normal coronary arteries. The
effect of aortic valve replacement in the prevention of
this serious event requires further investigation.
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